SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Chemcel Biotech Ltd (533026)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533026 NSE: Pesticides & Agrochemicals | Small Cap | Chemcel Biotech Share Price

BSE Share Price
Not Listed

Chemcel Biotech Ltd (533026)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533026 NSE: Pesticides & Agrochemicals | Small Cap | Chemcel Biotech Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹3 Cr.
Current Price
₹0
52-Week Low / High
₹1 / 1
TTM EPS
₹0.1
TTM Sales
₹41.1 Cr.
Book Value per Share
₹15.6
P/E Ratio
15.98
Industry PE
31.4
Price to Book (P/B)
0.06
Price to Sales (P/S)
0.06
EV/EBITDA
6.18
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
2.11%
Return on Capital Employed (ROCE)
4.65%
Return on Assets (ROA)
1.50%
Operating Profit Margin
4.9%
Net Profit Margin
1.73%
Gross Profit Margin
2.4%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
9.62%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-15.7%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
-36.5%
Asset Quality
Promoter Holding
20.01%
Pledged shares (%) of Promoter's holding (%)
76.06%
Reserves
₹16 Cr.
Equity
₹27.9 Cr.
Face Value
₹10
All Time Low / High
₹0.95 / 16.00

Chemcel Biotech stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation ⓘ

Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11TTM
ROCE % ⓘ0%0%9%15.6%15%13.7%14.4%9.4%6.2%4.7%-

Growth Parameters ⓘ
Sales ⓘ0012.812.921.423.324.635.245.850.241
Sales YoY Gr.-NANA0.6%65.5%9.2%5.3%43.2%30%9.6%-
Adj EPS ⓘ001.22.61.10.91.20.50.50.30.1
YoY Gr.-NANA118%-57.3%-18.4%34.8%-57.5%3.9%-41.5%-
BVPS (₹) ⓘ0010.81110.711.512.614.615.315.315.6
Adj Net
Profit ⓘ		000.10.20.70.91.31.31.40.90
Cash Flow from Ops. ⓘ000.6-1.4-5.7-6.5-0.1-14.1-5-3.8-
Debt/CF from Ops. ⓘ003.4-2.6-0.8-1-53.2-0.4-1.9-2.7-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNA18.6%26.8%9.6%
Adj EPS ⓘNA-22.2%-36.3%-41.5%
BVPSⓘNA7.5%6.6%0.2%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11TTM
Return on
Equity % ⓘ		007.810.415.19.89.953.420.4
Op. Profit
Mgn % ⓘ		003.36.56.49.311.88.76.44.95
Net Profit
Mgn % ⓘ		000.71.43.445.13.731.70.4
Debt to
Equity ⓘ		002.54.50.70.50.50.10.20.2-
Working Cap
Days ⓘ		0001801662843763263263480
Cash Conv.
Cycle ⓘ		000110931101241772012210

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11
Sales12.8412.9121.3723.3424.5835.1945.7650.16
Operating Expenses ⓘ + 12.4212.0720.0121.1621.6732.1442.8347.69
Manufacturing Costs6.186.0415.2817.1418.690.020.220.08
Material Costs-0.580.67-0.35-0.13-0.0427.2938.6845.28
Employee Cost 0.550.460.510.480.570.800.550.55
Other Costs ⓘ 6.284.904.563.672.464.033.391.79
Operating Profit ⓘ 0.420.841.362.172.903.052.932.47
Operating Profit Margin (%) 3.3%6.5%6.4%9.3%11.8%8.7%6.4%4.9%
Other Income ⓘ + 000.080.010000
Exceptional Items ⓘ 00000000
Interest ⓘ 0.100.240.420.601.151.201.061.24
Depreciation ⓘ 0.140.140.130.120.110.100.090.08
Profit Before Tax ⓘ 0.170.460.901.461.651.751.791.15
Tax ⓘ 0.090.280.140.520.390.440.410.28
Profit After Tax 0.080.180.760.941.261.311.370.87
PAT Margin (%) 0.7%1.4%3.5%4.0%5.1%3.7%3.0%1.7%
Adjusted EPS (₹)1.22.61.10.91.20.50.50.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%

Valuation of Chemcel Biotech - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11

Equity and Liabilities

Shareholders Fund + 0.780.837.1112.0813.3039.0540.5843.44
Share Capital ⓘ 0.720.726.6510.5210.5225.9225.9227.92
Reserves ⓘ 0.060.110.461.562.7913.1314.6615.52
Debt +1.963.524.606.447.025.059.5910.07
Long Term Debt1.963.524.606.447.025.059.5910.07
Short Term Debt00000000
Minority Interest00000000
Trade Payables1.670.731.613.303.351.053.231.45
Others Liabilities ⓘ 2.622.996.183.074.641.992.495.15
Total Liabilities ⓘ 7.028.0619.5024.8928.3147.1455.8960.12

Fixed Assets

Net Fixed Assets ⓘ +1.131.091.100.991.291.231.151.07
Gross Block1.281.231.231.242.282.312.322.32
Accumulated Depreciation0.140.140.130.250.991.081.171.25
CWIP ⓘ 005.800.1307.377.377.37
Investments ⓘ 0.010.01000.030.030.030.03
Inventories1.500.831.181.311.353.334.945.41
Trade Receivables3.724.926.6010.6311.2623.8524.2232.40
Cash Equivalents 0.040.0200.010.140.070.030
Others Assets ⓘ 0.621.204.8211.8314.2311.2618.1513.83
Total Assets ⓘ 7.028.0619.5024.8928.3147.1455.8960.12

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11
Cash Flow From Operating Activity ⓘ + 0.57-1.35-5.68-6.48-0.13-14.08-4.98-3.77
PBT ⓘ 0.170.460.901.461.761.751.791.15
Adjustment ⓘ 0.150.150.140.14-0.41-0.34-0.33-0.20
Changes in Working Capital ⓘ 0.33-1.9-6.72-8.08-1.48-15.49-6.44-4.71
Tax Paid ⓘ -0.08-0.06000000
Cash Flow From Investing Activity ⓘ + -0.50-0.15-5.795.65-0.31-8.670.250.25
Capex -0.50-0.1000.01-0.41-0.03-0.010
Net Investments 000.010-0.03000
Others ⓘ 0-0.05-5.805.640.13-8.630.250.25
Cash Flow From Financing Activity ⓘ + -0.041.4811.450.840.5822.674.693.48
Net Proceeds from Shares ⓘ 0.1505.933.87024.640.163
Net Proceeds from Borrowing ⓘ 0.341.901.222.010000
Interest Paid ⓘ 00000000
Dividend Paid ⓘ -0.08-0.08-0.13-0.390000
Others ⓘ -0.45-0.344.44-4.650.58-1.974.540.48
Net Cash Flow ⓘ 0.03-0.02-0.010.010.13-0.07-0.04-0.03

Financial Ratio

PARTICULARSMar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11
Ratios
ROE (%)10.7823.4319.239.789.955.143.552.11
ROCE (%)9.0315.5514.9613.6514.429.356.184.65
Asset Turnover Ratio1.831.711.551.050.920.950.910.88
PAT to CFO Conversion(x)7.13-7.5-7.47-6.89-0.1-10.75-3.64-4.33
Working Capital Days
Receivable Days105.70122.1098.40134.70162.50178.70187.80202.70
Inventory Days42.703317.2019.4019.7023.8032.3037
Payable Days-1,050.10652.60-1,235.10-6,879.40029.4020.2018.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *18.370.000.0037.6337.7537.7537.7564.8474.7276.06
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Chemcel Biotech Ltd FAQs

The current trading price of Chemcel Biotech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Chemcel Biotech stood at ₹2.65 Cr

The latest P/E ratio of Chemcel Biotech as of 31-Dec-1969 is 15.98.

The latest P/B ratio of Chemcel Biotech as of 31-Dec-1969 is 0.06.

The 52-week high of Chemcel Biotech is ₹0.95 and the 52-week low is ₹0.95.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chemcel Biotech is ₹41.09 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Chemcel Biotech Ltd

Chemcel Biotech was originally incorporated as ‘Chemcel Products Limited’ on September 29, 1995 under the Companies Act, 1956 in the State of Andhra Pradesh, India. The name of the Company was changed to Chemcel Bio-Tech Limited with effect fro  January 4, 2001.

Chemcel Biotech Ltd was incorporated with the main objective of manufacturing of Agro Chemicals. Later on it started producing bio-fertilisers and bio-pesticides also. In order to reflect this activity, the company changed its name as Chemcel Biotech Limited, with effect from January 04, 2001.

It is a premium manufacturer of agro chemicals comprising of insecticides, Fungicides and plant growth promoters. The unit' s registered office & factory are located in JRD Tata Industrial Estate, Vijayawada.

The company has been promoted by K.Bala Krishna Rao, K.T.Vijay Kumar & KCS Prasad. All these promoters have earlier worked with some of the leading agrochemicals/pesticides manufacturing companies in various capacities and have rich experience in this industry.

The company’s Registered office and factory are located at Tata Industrial estate, Kanuru, Vijayawada, their own premises. The total area of the plot of land is about 1849.02 sq.yards. It has two RCC buildings with 3 floors in each building constructed on the plot. The company has all the necessary plant & machinery & other infrastructure to attain a turnover of Rs.60.00 Crores.

The company already imported pilot plant from U.K-“Mark and Simon Associates” to manufacture Bio-diesel.

Product range of the company includes:

  • Hexa  
  • Cosy 
  • Counter  
  • Celphate
  • Monocel 
  • Chase  
  • Bumper  
  • Cythrin
  • Care  Quintox 
  • Cheminocel SP  Lead
  • Cheminocel SL  
  • Cordite

Achievements/ recognition:

  • Awarded as best Industry. Chemcel Biotech Limited (CBL) is the winner of the Best Entrepreneur award from JRD Tata Industrial Estate, Vijaywada.
  • Chemcel Biotech Limited (CBL) is the winner of the Best Entrepreneur award from JRD Tata Industrial Estate, Vijaywada.
You have 3 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: